Karla Palmer has over 25 years of experience as a litigator. Her focus at Hyman, Phelps & McNamara, P.C., is on DEA and FDA enforcement and litigation matters. Karla also advises clients throughout the supply chain on a range of issues, including DEA and FDA regulations and guidance, government inspections (including Form 483s) and investigations, warning letters, consent decrees, and administrative and federal proceedings. In addition, she has written about and addressed industry audiences on all aspects of the passage and implementation of the 2013 Drug Quality and Security Act, including both compounding and supply chain issues, its guidance documents and implementing regulations. She is well-versed on the DSCSA and on compounding laws, regulations and guidance, and regularly counsels clients throughout the nation on these matters.